Leap Therapeutics Stock Price on December 2, 2024
| LPTX Stock | USD 3.16 0.04 1.25% |
Below is the normalized historical share price chart for Leap Therapeutics extending back to January 25, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Leap Therapeutics stands at 3.16, as last reported on the 11th of December 2024, with the highest price reaching 3.27 and the lowest price hitting 3.13 during the day.
If you're considering investing in Leap Stock, it is important to understand the factors that can impact its price. Leap Therapeutics appears to be relatively risky, given 3 months investment horizon. Leap Therapeutics has Sharpe Ratio of 0.06, which conveys that the firm had a 0.06% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Leap Therapeutics, which you can use to evaluate the volatility of the firm. Please exercise Leap Therapeutics' Downside Deviation of 4.47, mean deviation of 4.19, and Risk Adjusted Performance of 0.0504 to check out if our risk estimates are consistent with your expectations.
At this time, Leap Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Total Equity is likely to rise to about 106.3 K in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 45.2 M in 2024. . At this time, Leap Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.06 in 2024, whereas Price To Sales Ratio is likely to drop 109.75 in 2024. Leap Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of January 2017 | 200 Day MA 2.6405 | 50 Day MA 2.9487 | Beta 0.217 |
Leap |
Sharpe Ratio = 0.06
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | LPTX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.72 actual daily | 50 50% of assets are less volatile |
Expected Return
| 0.34 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Leap Therapeutics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Leap Therapeutics by adding it to a well-diversified portfolio.
Price Book 2.5595 | Enterprise Value Ebitda 0.4706 | Price Sales 160.1041 | Shares Float 26.1 M | Wall Street Target Price 11.375 |
Related Headline
Vericel Corp Headline on 2nd of December 2024
Acquisition by Hopper Jonathan Mark of 10000 shares of Veric... by MacroaxisInsider
Filed transaction by Vericel Corp Ord Officer: Chief Medical Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Leap Therapeutics Valuation on December 2, 2024
It is possible to determine the worth of Leap Therapeutics on a given historical date. On December 2, 2024 Leap was worth 3.02 at the beginning of the trading date compared to the closed value of 2.9. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Leap Therapeutics stock. Still, in general, we apply an absolute valuation method to find Leap Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Leap Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Leap Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.95 | 3.18 | 2.90 | 2.98 | 212,197 | |
12/02/2024 | 3.02 | 3.08 | 2.86 | 2.90 | 162,442 |
| 2.89 | 2.97 | 2.75 | 2.79 | 186,122 |
| Backtest Leap Therapeutics | | | Leap Therapeutics History | | | Leap Therapeutics Valuation | Previous | Next |
Leap Therapeutics Trading Date Momentum on December 2, 2024
| On December 03 2024 Leap Therapeutics was traded for 2.79 at the closing time. The top price for the day was 2.97 and the lowest listed price was 2.75 . The trading volume for the day was 186.1 K. The trading history from December 3, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 3.79% . The trading delta at closing time against the current closing price is 9.66% . |
Leap Therapeutics Fundamentals Correlations and Trends
By evaluating Leap Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Leap Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Leap financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Leap Therapeutics Stock history
Leap Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Leap is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Leap Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Leap Therapeutics stock prices may prove useful in developing a viable investing in Leap Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 20.4 M | 21.5 M | |
| Net Loss | -49.1 M | -46.7 M |
Leap Therapeutics Quarterly Net Working Capital |
|
Leap Therapeutics Stock Technical Analysis
Leap Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Leap Therapeutics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Leap Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Leap Therapeutics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Leap Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Leap Therapeutics shares will generate the highest return on investment. By undertsting and applying Leap Therapeutics stock market strength indicators, traders can identify Leap Therapeutics entry and exit signals to maximize returns
Leap Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Leap Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Leap Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Leap to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0504 | |||
| Jensen Alpha | 0.1982 | |||
| Total Risk Alpha | (0.57) | |||
| Sortino Ratio | 0.0443 | |||
| Treynor Ratio | 0.313 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Leap Stock Analysis
When running Leap Therapeutics' price analysis, check to measure Leap Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Leap Therapeutics is operating at the current time. Most of Leap Therapeutics' value examination focuses on studying past and present price action to predict the probability of Leap Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Leap Therapeutics' price. Additionally, you may evaluate how the addition of Leap Therapeutics to your portfolios can decrease your overall portfolio volatility.